These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 32973060)

  • 1. Impact of low-dose CT screening for lung cancer on ethnic health inequities in New Zealand: a cost-effectiveness analysis.
    McLeod M; Sandiford P; Kvizhinadze G; Bartholomew K; Crengle S
    BMJ Open; 2020 Sep; 10(9):e037145. PubMed ID: 32973060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of a low-dose computed tomography screening programme for lung cancer in New Zealand.
    Jaine R; Kvizhinadze G; Nair N; Blakely T
    Lung Cancer; 2018 Oct; 124():233-240. PubMed ID: 30268467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal Cancer Screening: How Health Gains and Cost-Effectiveness Vary by Ethnic Group, the Impact on Health Inequalities, and the Optimal Age Range to Screen.
    McLeod M; Kvizhinadze G; Boyd M; Barendregt J; Sarfati D; Wilson N; Blakely T
    Cancer Epidemiol Biomarkers Prev; 2017 Sep; 26(9):1391-1400. PubMed ID: 28626068
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-effectiveness of a low-dose computed tomography screening programme for lung cancer in New Zealand.
    Jaine R; Kvizhinadze G; Nair N; Blakely T
    Lung Cancer; 2020 Jun; 144():99-106. PubMed ID: 32317183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
    Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
    Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the economic costs of Indigenous health inequities in New Zealand: a retrospective cohort analysis.
    Reid P; Paine SJ; Te Ao B; Willing EJ; Wyeth E; Vaithianathan R; Loring B
    BMJ Open; 2022 Oct; 12(10):e065430. PubMed ID: 36265912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of mammographic screening on ethnic and socioeconomic inequities in breast cancer stage at diagnosis and survival in New Zealand: a cohort study.
    Seneviratne S; Campbell I; Scott N; Shirley R; Lawrenson R
    BMC Public Health; 2015 Jan; 15():46. PubMed ID: 25637343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The estimated health impact of alcohol interventions in New Zealand: A modelling study.
    Chambers T; Mizdrak A; Herbert S; Davies A; Jones A
    Addiction; 2024 Jan; 119(1):125-136. PubMed ID: 37649140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of docetaxel versus weekly paclitaxel in adjuvant treatment of regional breast cancer in New Zealand.
    Webber-Foster R; Kvizhinadze G; Rivalland G; Blakely T
    Pharmacoeconomics; 2014 Jul; 32(7):707-24. PubMed ID: 24859241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of Low-Dose Computed Tomography With a Plasma-Based Biomarker for Lung Cancer Screening in China.
    Zhao Z; Wang Y; Wu W; Yang Y; Du L; Dong H
    JAMA Netw Open; 2022 May; 5(5):e2213634. PubMed ID: 35608858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health gains, costs and cost-effectiveness of a population-based screening programme for abdominal aortic aneurysms.
    Nair N; Kvizhinadze G; Jones GT; Rush R; Khashram M; Roake J; Blakely A
    Br J Surg; 2019 Jul; 106(8):1043-1054. PubMed ID: 31115915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness and health impact of lung cancer screening with low-dose computed tomography for never smokers in Japan and the United States: a modelling study.
    Kowada A
    BMC Pulm Med; 2022 Jan; 22(1):19. PubMed ID: 34996423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biennial lung cancer screening in Canada with smoking cessation-outcomes and cost-effectiveness.
    Goffin JR; Flanagan WM; Miller AB; Fitzgerald NR; Memon S; Wolfson MC; Evans WK
    Lung Cancer; 2016 Nov; 101():98-103. PubMed ID: 27794416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of lung MRI in lung cancer screening.
    Allen BD; Schiebler ML; Sommer G; Kauczor HU; Biederer J; Kruser TJ; Carr JC; Hazen G
    Eur Radiol; 2020 Mar; 30(3):1738-1746. PubMed ID: 31748855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness and equity impacts of three HPV vaccination programmes for school-aged girls in New Zealand.
    Blakely T; Kvizhinadze G; Karvonen T; Pearson AL; Smith M; Wilson N
    Vaccine; 2014 May; 32(22):2645-56. PubMed ID: 24662710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining cost-effectiveness of lung cancer screening in urban Chinese populations using a state-transition Markov model.
    Sun C; Zhang X; Guo S; Liu Y; Zhou L; Shi J; Wu N; Zhai Z; Liu G
    BMJ Open; 2021 Jul; 11(7):e046742. PubMed ID: 34210726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography for High-Risk Smokers in Australia.
    Wade S; Weber M; Caruana M; Kang YJ; Marshall H; Manser R; Vinod S; Rankin N; Fong K; Canfell K
    J Thorac Oncol; 2018 Aug; 13(8):1094-1105. PubMed ID: 29689434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Transport on Population Health and Health Equity for Māori in Aotearoa New Zealand: A Prospective Burden of Disease Study.
    Randal E; Shaw C; McLeod M; Keall M; Woodward A; Mizdrak A
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality trends in Australian Aboriginal peoples and New Zealand Māori.
    Phillips B; Daniels J; Woodward A; Blakely T; Taylor R; Morrell S
    Popul Health Metr; 2017; 15():25. PubMed ID: 28680369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk-Targeted Lung Cancer Screening: A Cost-Effectiveness Analysis.
    Kumar V; Cohen JT; van Klaveren D; Soeteman DI; Wong JB; Neumann PJ; Kent DM
    Ann Intern Med; 2018 Feb; 168(3):161-169. PubMed ID: 29297005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.